| |
|
 |
Session 1
Chaired by Dr Malcolm Duckworth |
|
|
 |
Exploration of Aminothiazoles as Potent and Selective Adenosine Receptor Antagonists
Dr Neil Press
|
|
|
|
|
|
The Syntheses and Properties of Some Novel P2Y2 Receptor Agonists
Dr. Verity Sabin
|
|
|
|
|
|
A Novel Concept of Reversing Neuromuscular Block
Dr Ronnie Palin
|
|
|
|
|
Session 2
Chaired by Dr Simon Hodgson |
|
|
|
Gastrin Receptor Antagonists: A Rational Approach?
Dr Barret Kalindjian
|
|
|
|
|
|
The Design of Potent and Selective Sulphamide ET-A Receptor Antagonists
Dr Mike Palmer
|
|
|
|
|
|
Will Subtype Selective Neuronal Nicotinic Receptor Ligands Make Useful Drugs?
Dr Richard Baker
|
|
|
|
|
|
Structure Based Screening of Drug Fragments in Lead Discovery
Dr Paul Wyatt
|
|
|
|
|
Session 3
Chaired by |
|
|
|
The Discovery of Potent Selective Antagonists of the Human Melanin-Concentrating Hormone Receptor 11CBy
Dr David Witty
|
|
|
|
|
